No Commercialization Sample Clauses

The No Commercialization clause prohibits the use of certain materials, information, or intellectual property for commercial purposes. In practice, this means that parties are not allowed to sell, license, or otherwise exploit the covered content for profit, even if they have access to it for other permitted uses such as research or internal evaluation. This clause serves to protect the owner’s interests by preventing unauthorized commercial gain and ensuring that the materials are used only within the agreed non-commercial scope.
POPULAR SAMPLE Copied 6 times
No Commercialization. Seller has not in any way commercialized or engaged in any business activities with third parties with respect to the Purchased Assets that relate to the Business other than the internal development of the Owned IP that relates primarily to the Business.
View Source
No Commercialization. Sub-Recipient agrees that it shall not commercialize or, except as expressly permitted under the terms of this Agreement, otherwise Exploit any Materials, Information or Inventions owned by or licensed to NCDMM.
View SourceView Similar (2)
No Commercialization. Thera Europe shall have the right to terminate this Agreement on a Product-by-Product and Country-by-Country basis if the First Commercial Sale of a Product does not occur within [REDACTED: Term] for such Product. Termination under this Section 14.5 shall be the sole remedy of Thera Europe in respect of the Product(s) and Countr(y)(ies) in question save that nothing herein shall exclude ▇▇▇▇▇▇’▇ indemnification obligations in respect of named patient supplies made in a Country of the Territory.
View Source
No Commercialization. Sanofi and its Affiliates are not Commercializing any Restricted Compound.
View SourceView Similar (2)
No Commercialization. VPPPA does not endorse commercial products / services or lobby commercial products / services for specific legislation. Speakers are not permitted to sell, promote or otherwise give significant exposure to any company or organization's materials, products and/or services. Advertising, informational literature, samples, etc., in meeting rooms, corridors, guest rooms or other adjacent areas are not permitted. This restriction also applies to printed matter promoting sessions or activities of other non-VPPPA groups. A company can give introduction of their company and what they do, but cannot use the workshop as a sales pitch for their company.
View Source
No Commercialization. Seller agrees that it shall not commercialize or, except as expressly permitted under the terms of this contract, otherwise Exploit any Materials, Information or Inventions owned by or licensed to NCDM Publication. Seller, including its Affiliates and any permitted subcontractors and its or their respective employees or agents, has no right to publish the Buyer or Buyer’s customer’s name or logo, except as expressly consented to in writing by the Buyer.
View Source
No Commercialization. Without limiting any of the above restrictions and limitations, for the avoidance of doubt, Licensee and/or End Users shall not, directly or indirectly, charge a fee or fees to any other End User for access to or use of the Software or any Models made available therein without AnyLogic’s prior written consent. By way of example only and without limiting such prohibitions, Licensee may not develop a product or services that uses the Software (or any Models made available therein) for which Licensee charges a third-party person access to or use of said product or service without first obtaining AnyLogic’s prior written approval (and subject to any additional fees AnyLogic may impose).
View Source

Related to No Commercialization

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.

  • Joint Commercialization Committee Upon a decision by the JSC to activate the joint Commercialization committee, but in no case later than eighteen (18) months prior to the projected First Commercial Sale (the “Joint Commercialization Committee” or “JCC”), the Parties shall establish the JCC. The JCC shall hold its initial meeting within thirty (30) days of its establishment. Following its initial meeting, the JCC will meet in person, by teleconference or by video-teleconference at least [***] per [***] to review and discuss material decisions and key activities that relate to the matters set forth below. The JCC will be responsible for the communication, review and discussion of the Commercialization Plan and other Commercialization matters, including marketing strategy and planning, pricing, commercial manufacture, and [***], in each case in the Territory. Without limiting the foregoing, the JCC shall be responsible for: (a) reviewing and consulting with Coherus on the Commercialization Plan prior to adoption of the Commercialization Plan or changes by Licensee; (b) recommending the Commercialization Plan for approval by the JSC prior to adoption of the Commercialization Plan; (c) communicating with the JDC regarding the interrelationship between Development activities and potential Commercialization activities; (d) reviewing and monitoring the activities and progress against the Commercialization Plan; (e) monitoring and reporting on the competitive landscape for the Product in the Territory; (f) establishing appropriate processes for coordinating review of promotional materials for the Territory to ensure compliance with Applicable Laws and industry best practices; (g) overseeing the trademark and publication strategies for the Territory; and (h) communicating with the Parties regarding all of the foregoing.

  • Collaboration activities 4.1 The Collaboration Suppliers will perform the Collaboration Activities and all other obligations of this Agreement in accordance with the Detailed Collaboration Plan. 4.2 The Collaboration Suppliers will provide all additional cooperation and assistance as is reasonably required by the Buyer to ensure the continuous delivery of the services under the Call-Off Contract. 4.3 The Collaboration Suppliers will ensure that their respective subcontractors provide all cooperation and assistance as set out in the Detailed Collaboration Plan.